β-Phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype
Authors:
- Wen-Jing WuWWWen-Jing Wu
- Yan ZhangYZYan Zhang
- Zhao-Lei ZengZZZhao-Lei Zeng
- Xiao-Bing LiXLXiao-Bing Li
- Kai-Shun HuKHKai-Shun Hu
- Hui-Yan LuoHLHui-Yan Luo
- Jing YangJYJing Yang
- Peng HuangPHPeng Huang
- Rui-Hua XuRXRui-Hua Xu
- 1 February 2013
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 85 (4) , 486-496
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatinMolecular Nutrition & Food Research, 2011
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinomaBritish Journal of Cancer, 2011
- Sensitization of Non-small Cell Lung Cancer Cells to Cisplatin by Naturally Occurring IsothiocyanatesChemical Research in Toxicology, 2010
- Damaged DNA-binding Protein 1 (DDB1) Interacts with Cdh1 and Modulates the Function of APC/CCdh1Journal of Biological Chemistry, 2010
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper ChelatorCancer Cell, 2010
- Phenethyl Isothiocyanate Sensitizes Androgen-Independent Human Prostate Cancer Cells to Docetaxel-Induced Apoptosis In Vitro and In VivoPharmaceutical Research, 2010
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005